United Therapeutics Chairperson and CEO Martine A. Rothblatt reports sale of $5.56 million in common shares
UTHR•United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on Oct. 28, 2026, for about $5.56 million at weighted-average prices ranging from $583.5017 to $588.3913 per share.
1. Share sale and options
Rothblatt sold 9,500 common shares on Oct. 28, 2026, at weighted-average prices ranging from $583.5017 to $588.3913 per share. She also exercised options for 9,500 common shares at $117.76 per share. After the transactions, trusts involved held 324,443 common shares, Rothblatt separately held 40,513 shares directly, and 138,410 stock options remained held indirectly through a trust.
